Keyphrases
Antimicrobial
100%
Inhalable
100%
Sinusitis
100%
Cystic Fibrosis
100%
Bacterial Biofilm
100%
Drug Delivery System
100%
Pseudomonas Aeruginosa (P. aeruginosa)
60%
Formulation Design
40%
Sinus
40%
Disease Management
20%
Design Approach
20%
Nasal Cavity
20%
Chronic Pulmonary Infections
20%
Lung Infection
20%
Lower Respiratory Tract
20%
Biofilm Infection
20%
Inhalation Therapy
20%
Novel Antimicrobials
20%
Respiratory Tract
20%
Pseudomonas Aeruginosa Infection
20%
High Dose
20%
Drug Formulation
20%
P. Aeruginosa Infection
20%
Lung
20%
Fibrosis Diseases
20%
Reinfection
20%
Infection Site
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Sinusitis
100%
Infection
100%
Antiinfective Agent
80%
Pseudomonas aeruginosa
80%
Antimicrobial Agent
40%
Formulation Design
40%
Lung Infection
40%
Respiratory Tract
40%
Drug Formulation
20%
Diseases
20%
Reinfection
20%
Pseudomonas Infection
20%
Bacterial Sinusitis
20%